vs
UNIVERSAL DISPLAY CORP \PA\（OLED）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是UNIVERSAL DISPLAY CORP \PA\的1.4倍（$197.9M vs $142.2M），UNIVERSAL DISPLAY CORP \PA\净利率更高（25.2% vs 6.7%，领先18.5%），REPLIGEN CORP同比增速更快（13.6% vs -14.5%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -5.3%）
Universal Display Corporation（股票代码OLED）是有机发光二极管（OLED）技术及材料的研发与生产企业，拥有深厚的技术积累，面向显示、照明两大领域提供相关配套服务，是全球OLED上游产业链的核心供应商之一。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
OLED vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$142.2M
营收增速更快
RGEN
高出28.1%
-14.5%
净利率更高
OLED
高出18.5%
6.7%
两年增速更快
RGEN
近两年复合增速
-5.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $142.2M | $197.9M |
| 净利润 | $35.9M | $13.3M |
| 毛利率 | 74.6% | 52.5% |
| 营业利润率 | 30.1% | 9.0% |
| 净利率 | 25.2% | 6.7% |
| 营收同比 | -14.5% | 13.6% |
| 净利润同比 | -44.3% | 143.9% |
| 每股收益（稀释后） | $0.76 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OLEDRGEN
| Q1 26 | $142.2M | — | ||
| Q4 25 | $172.9M | $197.9M | ||
| Q3 25 | $139.6M | $188.8M | ||
| Q2 25 | $171.8M | $182.4M | ||
| Q1 25 | $166.3M | $169.2M | ||
| Q4 24 | $162.3M | $174.1M | ||
| Q3 24 | $161.6M | $154.9M | ||
| Q2 24 | $158.5M | $154.1M |
净利润OLEDRGEN
| Q1 26 | $35.9M | — | ||
| Q4 25 | $66.3M | $13.3M | ||
| Q3 25 | $44.0M | $14.9M | ||
| Q2 25 | $67.3M | $14.9M | ||
| Q1 25 | $64.4M | $5.8M | ||
| Q4 24 | $46.0M | $-30.3M | ||
| Q3 24 | $66.9M | $-654.0K | ||
| Q2 24 | $52.3M | $3.3M |
毛利率OLEDRGEN
| Q1 26 | 74.6% | — | ||
| Q4 25 | 76.1% | 52.5% | ||
| Q3 25 | 74.6% | 53.2% | ||
| Q2 25 | 77.2% | 50.0% | ||
| Q1 25 | 77.1% | 53.6% | ||
| Q4 24 | 77.0% | 26.1% | ||
| Q3 24 | 77.8% | 50.0% | ||
| Q2 24 | 75.8% | 49.8% |
营业利润率OLEDRGEN
| Q1 26 | 30.1% | — | ||
| Q4 25 | 38.9% | 9.0% | ||
| Q3 25 | 30.9% | 8.9% | ||
| Q2 25 | 39.9% | 7.6% | ||
| Q1 25 | 41.9% | 3.9% | ||
| Q4 24 | 32.3% | -17.7% | ||
| Q3 24 | 41.5% | -5.1% | ||
| Q2 24 | 35.6% | 1.0% |
净利率OLEDRGEN
| Q1 26 | 25.2% | — | ||
| Q4 25 | 38.4% | 6.7% | ||
| Q3 25 | 31.5% | 7.9% | ||
| Q2 25 | 39.2% | 8.2% | ||
| Q1 25 | 38.8% | 3.4% | ||
| Q4 24 | 28.4% | -17.4% | ||
| Q3 24 | 41.4% | -0.4% | ||
| Q2 24 | 33.0% | 2.2% |
每股收益（稀释后）OLEDRGEN
| Q1 26 | $0.76 | — | ||
| Q4 25 | $1.40 | $0.24 | ||
| Q3 25 | $0.92 | $0.26 | ||
| Q2 25 | $1.41 | $0.26 | ||
| Q1 25 | $1.35 | $0.10 | ||
| Q4 24 | $0.96 | $-0.55 | ||
| Q3 24 | $1.40 | $-0.01 | ||
| Q2 24 | $1.10 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $516.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | — | $2.1B |
| 总资产 | $1.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资OLEDRGEN
| Q1 26 | $516.4M | — | ||
| Q4 25 | $602.4M | $767.6M | ||
| Q3 25 | $603.0M | $748.7M | ||
| Q2 25 | $525.2M | $708.9M | ||
| Q1 25 | $571.3M | $697.2M | ||
| Q4 24 | $492.7M | $757.4M | ||
| Q3 24 | $551.6M | $784.0M | ||
| Q2 24 | $530.5M | $809.1M |
总债务OLEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益OLEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $2.1B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B |
总资产OLEDRGEN
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.0B | $2.9B | ||
| Q3 25 | $1.9B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $1.8B | $2.8B | ||
| Q3 24 | $1.8B | $2.8B | ||
| Q2 24 | $1.8B | $2.9B |
负债/权益比OLEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 3.03× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流OLEDRGEN
| Q1 26 | $108.9M | — | ||
| Q4 25 | $31.1M | $25.7M | ||
| Q3 25 | $97.2M | $48.1M | ||
| Q2 25 | $51.9M | $28.6M | ||
| Q1 25 | $30.6M | $15.0M | ||
| Q4 24 | $34.7M | $39.2M | ||
| Q3 24 | $79.9M | $49.3M | ||
| Q2 24 | $67.0M | $42.2M |
自由现金流OLEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | $15.1M | $17.6M | ||
| Q3 25 | $84.3M | $43.4M | ||
| Q2 25 | $37.5M | $21.5M | ||
| Q1 25 | $17.5M | $11.4M | ||
| Q4 24 | $22.0M | $33.6M | ||
| Q3 24 | $66.2M | $42.3M | ||
| Q2 24 | $57.9M | $37.4M |
自由现金流率OLEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | 8.7% | 8.9% | ||
| Q3 25 | 60.4% | 23.0% | ||
| Q2 25 | 21.8% | 11.8% | ||
| Q1 25 | 10.5% | 6.8% | ||
| Q4 24 | 13.6% | 19.3% | ||
| Q3 24 | 41.0% | 27.3% | ||
| Q2 24 | 36.5% | 24.3% |
资本支出强度OLEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | 9.3% | 4.1% | ||
| Q3 25 | 9.2% | 2.5% | ||
| Q2 25 | 8.4% | 3.9% | ||
| Q1 25 | 7.9% | 2.1% | ||
| Q4 24 | 7.8% | 3.2% | ||
| Q3 24 | 8.4% | 4.5% | ||
| Q2 24 | 5.8% | 3.1% |
现金转化率OLEDRGEN
| Q1 26 | 3.03× | — | ||
| Q4 25 | 0.47× | 1.93× | ||
| Q3 25 | 2.21× | 3.23× | ||
| Q2 25 | 0.77× | 1.92× | ||
| Q1 25 | 0.47× | 2.57× | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 1.28× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OLED
| Material sales | $83.7M | 59% |
| Royalty and license fees | $54.2M | 38% |
| Contract research services | $4.3M | 3% |
RGEN
暂无分部数据
